The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Use of Electronic Health Record Data in Clinical Investigations.'' The draft guidance is intended to assist sponsors, clinical investigators, contract research organizations, institutional review boards (IRBs), and other interested parties on the use of electronic health record (EHR) data in FDA-regulated clinical investigations.
Document
Use of Electronic Health Record Data in Clinical Investigations; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Use of Electronic Health Record Data in Clinical Inve...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
81 FR 30540
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Use of Electronic Health Record Data in Clinical Investigations; Draft Guidance for Industry; Availability,” thefederalregister.org (May 17, 2016), https://thefederalregister.org/documents/2016-11564/use-of-electronic-health-record-data-in-clinical-investigations-draft-guidance-for-industry-availability.